Oregon Health And Science University
New data further support novel treatment for Cushing’s syndrome
Pandemic spurs paradigm shift in artificial intelligence
Guidance for pituitary disease management during COVID-19
Telehealth shift during COVID-19 pandemic shows capacity to deliver safe, convenient care

As clinicians around the country rapidly transition from in-person to telehealth visits during the COVID-19 pandemic, many changes must be managed at once. Endocrinologists in particular are working to find new ways to support people with diabetes who rely on data-driven care and multiple in-person visits each year, as well as patients with other chronic endocrine conditions that require close follow-up, such as osteoporosis, pituitary tumors or adrenal disease.
Quality of life assessments in oncology trials often don’t — but should — go ‘well beyond treatment’
‘Sound evidence base’ needed amid growing acceptance of cannabis for patients with cancer
Palliative care flourishing but ‘significant hurdles’ remain
Industry payments to academic oncologists common, sometimes sizable compared with salaries
NTM lung disease: Assessment and determining course of treatment

Nontuberculous mycobacterial (NTM) lung disease is a chronic and debilitating condition, and although considered rare, some studies have estimated that prevalence is increasing about 8% each year in the United States. In 2019, it was estimated that 98,000 to 113,000 patients were diagnosed with the condition, according to unpublished data.
Targeted conditioning improves transplant rate for relapsed, refractory AML
ORLANDO — Targeted conditioning with anti-CD45 iodine apamistamab enabled older, heavily pretreated patients with relapsed or refractory acute myeloid leukemia to undergo hematopoietic stem cell transplantation with successful engraftment, according to preliminary results of the randomized phase 3 SIERRA trial presented at TCT | Transplantation & Cellular Therapy Meetings.